Four cases of disseminated herpes simplex virus following talimogene laherparepvec injections for unresectable metastatic melanoma.
JAAD Case Rep
; 33: 56-58, 2023 Mar.
Article
em En
| MEDLINE
| ID: mdl-36860805
IMLYGIC; T-VEC; acyclovir; adverse events; adverse reactions; dermatology; disseminated herpes infection; drug eruption; drug reactions; drug-induced reactions; herpes encephalitis; herpes simplex virus 1; immunotherapy; intralesional injections; malignant melanoma; melanoma; metastatic melanoma; oncolytic injection; oncolytic virus; regional chemotherapy; regional therapy; skin cancer; surgical oncology; talimogene laherparepvec; valacyclovir; viral dermatitis; viral encephalitis; viral rash
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article